当前存在宏观恶性肿瘤的肿瘤患者中偶发肺栓塞:不同肿瘤类型的发生率及延迟治疗对生存结局的影响
回顾英国两家区级综合医院2015年全年肿瘤患者胸部增强CT报告,1,604次扫描(731例患者)中报告26例偶发肺栓塞,发生率为1.6%,全部为转移性疾病。抗凝开始延迟超过5天的患者无一在3个月内死亡,无猝死发生;16例复查分期CT中偶发肺栓塞均消失,其中1例段性肺栓塞未接受抗凝。
要点
- 肿瘤患者胸部增强CT中偶发肺栓塞发生率低,为1.6%(26/1,604次扫描)。
- 偶发肺栓塞主要见于肺癌、乳腺癌和结直肠癌,可能与这些肿瘤影像检查频率高有关。
- 抗凝延迟数天似乎不影响猝死风险,抗凝开始超过5天的患者无一在3个月内死亡。
核心结论
- 当前存在宏观恶性肿瘤的患者中偶发肺栓塞发生率低(1.6%),主要见于肺癌、乳腺癌和结直肠癌,可能因这些肿瘤影像检查频繁;抗凝延迟数天似乎不影响猝死风险。
研究设计与样本
- 回顾性研究,纳入2015年1月1日至2015年12月31日英国两家区级综合医院肿瘤患者的胸部增强CT报告,共1,604次扫描(731例患者)。
关键影像表现/征象
- 26例偶发肺栓塞中,主肺动脉10例、叶动脉8例、段动脉7例、亚段动脉1例。
- 所有偶发肺栓塞患者均为转移性疾病,无猝死发生。
- 16例患者在抗凝后平均3.4个月复查分期CT,偶发肺栓塞均消失,其中1例段性肺栓塞患者未接受抗凝。
诊断标准与关键数值
- 偶发肺栓塞发生率1.6%(26/1,604次扫描)。
- 女性15例,中位年龄66岁(范围32-90岁)。
- 从扫描到报告的中位时间1天(范围0-60天),从扫描到抗凝的中位时间5天(范围0-61天),3例未治疗。
- 从扫描到死亡的中位时间7个月(范围1-22+个月),9例仍存活,2例失访。
临床应用与阅片要点
- 肿瘤患者胸部增强CT报告中偶发肺栓塞发生率低,但需注意在肺癌、乳腺癌和结直肠癌患者中识别。
- 抗凝开始超过5天的患者无一在3个月内死亡,提示抗凝延迟数天似乎不影响猝死风险。
- 本研究中1例段性肺栓塞患者未接受抗凝,复查分期CT未见偶发肺栓塞。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate the incidence and outcome of incidental pulmonary embolism (iPE) in patients with current macroscopic malignancy and delayed anticoagulation due to late reporting of CT scan.
METHODS: Reports of CT thorax with i.v. contrast done on oncology patients between 1 January 2015 and 31 December 2015 in two district general hospitals in UK were reviewed. Electronic patient records of iPE patients were reviewed for demographic and treatment information.
RESULTS: 26 iPEs were reported in 1,604 scans (731 patients), incidence 1.6%; female = 15; median age = 66 (range 32-90); main artery = 10; lobar artery = 8; segmental = 7; subsegmental = 1; median time (range) from scan to reporting = 1 day (0-60); scan to anticoagulation = 5 days (0-61) (three had no treatment); scan to death = 7 months (1-22+) with nine still alive and two lost to follow up. All had metastatic disease. There was no sudden death. None of the patients whose anticoagulation started more than 5 days after the iPE CT scan died within 3 months. iPE was absent in all repeat staging CT scans (done average 3.4 months after the anticoagulation) in 16 patients, without any anticoagulation in one patient with segmental iPE.
CONCLUSION: Incidence of iPE in patients with current macroscopic malignancy is low-1.6%-mostly seen in lung, breast and colorectal cancer probably due to frequency of imaging. A few days' delay in anticoagulation does not appear to have an impact on the risk of sudden cardiac death. Advances in knowledge: This study tells us that iPE is infrequent, that it can be treated appropriately with anticoagulation, but this does not necessarily need to begin on the same day of diagnosis.
引用
- Myat Moe MM, Redla S. Incidental pulmonary embolism in oncology patients with current macroscopic malignancy: incidence in different tumour type and impact of delayed treatment on survival outcome. Br J Radiol. 2018. PMID: 29688026. doi:10.1259/bjr.20170806
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。